Effectiveness of Topical Glycerine Sulphate Paste, Hirudoid Cream and Nil Application on Superficial Phlebitis

To Investigate the Effectiveness of Topical Glycerine Sulphate, Hirudoid Cream and Nil Application in Treating Peripheral Cannula Related Phlebitis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01226069

Enrollment

147

Registered

2010-10-21

Start date

2009-11-30

Completion date

2010-02-28

Last updated

2010-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

superficial phlebitis, cannula-related vein inflammation, Glycerine magnesium sulphate, Hirudoid cream, Nursing

Brief summary

The aim of the interventional study is to compare the different treatment modalities in reducing erythema size and rate of resolving phlebitis.

Interventions

DRUGGlycerine Magnesium sulphate paste

Dosage to apply adheres to the manufacturer's recommendation. Sufficient amount should cover the erythema size. Dose frequency is 12 hourly.

DRUGMucopolysaccharide polysulphate

Dosage to apply adheres to the manufacturer's recommendation. Sufficient amount should cover the erythema size. Dose frequency is 12 hourly.

OTHERNo application

No application

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients admitted to the study institution between Dec 2009 and Feb 2010 and observed to develop redness associated with peripheral infusion cannula.

Exclusion criteria

* Thrombosis, poor skin condition, and pus seen at the previous puncture.

Design outcomes

Primary

Measure	Time frame	Description
Erythema size	5 days	The incremental percentage change in erythema size

Secondary

Measure	Time frame	Description
Time to resolve redness	5 days	The rate of phlebitis resolution

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026